Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 years ago

Possible Interaction: Eicosapentaenoic Acid and Urokinase-Type Plasminogen Activator

Research Papers that Mention the Interaction

Recurrent uPA and ePA can also lead to agoraphobia, where subjects with PD avoid situations that were associated with PA.
Neuroscience & Biobehavioral Reviews  •  2014  |  View Paper
This phenomenon may be explained by the fact that certain EFAs, such as gamma-linolenic acid (GLA) and eicosapentaenoic acid (EPA), inhibit uPA activity.
Prostaglandins, leukotrienes, and essential fatty acids  •  1996  |  View Paper
Both GLA (n-6) and EPA (n-3) acted as competitive inhibitors of UK with Ki values of 120 and 96 microM respectively.
Prostaglandins, leukotrienes, and essential fatty acids  •  1994  |  View Paper